Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Gitanjali, Paul"'
Publikováno v:
Kidney International Reports, Vol 3, Iss 4, Pp 841-850 (2018)
Introduction: Hyporesponsiveness to recombinant human erythropoietin (rhEPO) is a major problem affecting some patients with chronic kidney disease (CKD), predominantly those on hemodialysis (HD). Daprodustat (GSK1278863) is a hypoxia-inducible facto
Externí odkaz:
https://doaj.org/article/d52ce01df2734f54b89b9c72e96d04d5
Autor:
Ajay K. Singh, Borut Cizman, Kevin Carroll, John J. V. McMurray, Vlado Perkovic, Vivekanand Jha, Kirsten L. Johansen, Renato D. Lopes, Iain C. Macdougall, Gregorio T. Obrador, Sushrut S. Waikar, Christoph Wanner, David C. Wheeler, Andrzej Wiecek, Nicole Stankus, Frank Strutz, Allison Blackorby, Alexander R. Cobitz, Amy M. Meadowcroft, Gitanjali Paul, Prerna Ranganathan, Sangeeta Sedani, Scott Solomon
Publikováno v:
JAMA internal medicine. 182(6)
Daprodustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor, is being evaluated as an oral alternative to conventional erythropoiesis-stimulating agent (ESA) therapy. Few studies of anemia treatment in an incident dialysis (ID) population ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2a5ad16d849ffe29bb73d762a40370c
https://pubmed.ncbi.nlm.nih.gov/35377393
https://pubmed.ncbi.nlm.nih.gov/35377393
Publikováno v:
Kidney International Reports, Vol 3, Iss 4, Pp 841-850 (2018)
Kidney International Reports
Kidney International Reports
Introduction: Hyporesponsiveness to recombinant human erythropoietin (rhEPO) is a major problem affecting some patients with chronic kidney disease (CKD), predominantly those on hemodialysis (HD). Daprodustat (GSK1278863) is a hypoxia-inducible facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5595e482b8f2d00497bc8b8e1839c739
https://doi.org/10.1016/j.ekir.2018.02.009
https://doi.org/10.1016/j.ekir.2018.02.009
Autor:
Cesar C. Bogado, Hui Jing Yu, John P. Bilezikian, Colin G. Miller, Gitanjali Paul, Lorraine A. Fitzpatrick, Antonio Nino, Alexander R. Cobitz, AR Northcutt, Margaret Wooddell, E. Michael Lewiecki
Publikováno v:
Journal of Clinical Densitometry. 19:485-491
Quantitative computed tomography (QCT) measurements have been used extensively to ascertain information about bone quality and density due to the 3-dimensional information provided and the ability to segment out trabecular and cortical bones. QCT ima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0433309a7ca04eb5963a1d08dd8546d6
https://doi.org/10.1016/j.jocd.2016.02.003
https://doi.org/10.1016/j.jocd.2016.02.003
Autor:
Bernard Zinman, Giancarlo Viberti, John M. Lachin, Steven E. Kahn, Gitanjali Paul, Rury R. Holman, Nigel P. Jones, Barbara G. Kravitz, William H. Herman, Steven M. Haffner, R. Paul Aftring
CONTEXT: An increase in bone fractures has been observed in women taking thiazolidinediones. OBJECTIVE: The objective of the study was to examine whether changes in circulating bone biomarkers provide insight into the underlying mechanisms responsibl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8760809a858dc67ed9030b76521b7cce
https://doi.org/10.1210/jc.2009-0572
https://doi.org/10.1210/jc.2009-0572
Autor:
John M, Lachin, Giancarlo, Viberti, Bernard, Zinman, Steven M, Haffner, R Paul, Aftring, Gitanjali, Paul, Barbara G, Kravitz, William H, Herman, Rury R, Holman, Steven E, Kahn
Publikováno v:
Clinical Journal of the American Society of Nephrology. 6:1032-1040
BACKGROUND AND OBJECTIVES: In ADOPT (A Diabetes Outcomes Prevention Trial), initial monotherapy with rosiglitazone provided more durable glycemic control than metformin or glyburide in patients with recently diagnosed type 2 diabetes. Herein, we exam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dc49e31caa3db266992f86a46285635
https://doi.org/10.2215/cjn.09291010
https://doi.org/10.2215/cjn.09291010
Autor:
Giancarlo Viberti, William H. Herman, Bernard Zinman, Steven E. Kahn, Steven M. Haffner, Gitanjali Paul, Rury R. Holman, John M. Lachin, Barbara G. Kravitz, R. Paul Aftring
Publikováno v:
Diabetes
OBJECTIVE ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial monotherapy with rosiglitazone provided superior durability of glycemic control compared with metformin and glyburide in patients with recently diagnosed type 2 diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b04c8d60a2cead92f1ac608a8b14e855
https://doi.org/10.2337/db10-1392
https://doi.org/10.2337/db10-1392
Autor:
Steven E. Kahn, Gitanjali Paul, Bernard Zinman, John M. Lachin, William H. Herman, Giancarlo Viberti, Rury R. Holman, Barbara G. Kravitz, Dahong Yu, Steven M. Haffner
Publikováno v:
Diabetes Care. 33:177-183
OBJECTIVE C-reactive protein (CRP) is closely associated with obesity and cardiovascular disease in both diabetic and nondiabetic populations. In the short term, commonly prescribed antidiabetic agents have different effects on CRP; however, the long
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11249a690d25686fb7b91e2067ca725a
https://doi.org/10.2337/dc09-1661
https://doi.org/10.2337/dc09-1661
Autor:
Gitanjali Paul, Thomas Mathew
Publikováno v:
Journal of Statistical Planning and Inference. 138:3982-3992
A p-value is developed for testing the equivalence of the variances of a bivariate normal distribution. The unknown correlation coefficient is a nuisance parameter in the problem. If the correlation is known, the proposed p-value provides an exact te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::422681b344ffe56255e472a1e349e9ca
https://doi.org/10.1016/j.jspi.2008.02.005
https://doi.org/10.1016/j.jspi.2008.02.005
Autor:
Antonio Nino, Richard Eastell, Northcutt Allison Ruth, Colin G. Miller, John P. Bilezikian, Barbara G. Kravitz, Alexander R. Cobitz, Gitanjali Paul, Margaret Wooddell, Robert G. Josse, E. Michael Lewiecki, Lorraine A. Fitzpatrick
Publikováno v:
The Journal of clinical endocrinology and metabolism. 98(4)
Postmenopausal status and type 2 diabetes mellitus (T2DM) are independent risk factors for fractures. An increased fracture risk has been observed with rosiglitazone (RSG), a thiazolidinedione, in patients with T2DM.This was a randomized, double-blin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b9fe4dc012cd64106fc53b1c7d8f0f8
https://pubmed.ncbi.nlm.nih.gov/23450056
https://pubmed.ncbi.nlm.nih.gov/23450056